Salivary Secretory Immunoglobulin (SIgA) and Lysozyme in Malignant Tumor Patients

Table 4

The concentration of salivary SIgA and lysozyme of hematopoietic system tumor patients.

	Pretreatment before transplantation ()	Regular treatment ()	P value
SIgA (µg/mL)	20.33 ± 3.12	21.54 ± 1.32	0.35
Lysozyme (ng/mL)	71.09 ± 16.53	54.26 ± 1.74	0.03